Goldman Sachs’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,084
Closed -$4.2K 5119
2023
Q2
$4.2K Buy
22,084
+2,100
+11% +$399 ﹤0.01% 4851
2023
Q1
$6.8K Hold
19,984
﹤0.01% 4987
2022
Q4
$6.46K Sell
19,984
-1,238
-6% -$400 ﹤0.01% 4983
2022
Q3
$9K Sell
21,222
-2,560
-11% -$1.09K ﹤0.01% 5270
2022
Q2
$10K Sell
23,782
-123
-0.5% -$52 ﹤0.01% 5522
2022
Q1
$30K Sell
23,905
-477
-2% -$599 ﹤0.01% 5551
2021
Q4
$32K Buy
24,382
+1
+0% +$1 ﹤0.01% 5410
2021
Q3
$50K Sell
24,381
-24,355
-50% -$49.9K ﹤0.01% 5192
2021
Q2
$77K Buy
48,736
+20,236
+71% +$32K ﹤0.01% 5183
2021
Q1
$63K Buy
28,500
+3,028
+12% +$6.69K ﹤0.01% 5105
2020
Q4
$63K Buy
25,472
+1,858
+8% +$4.6K ﹤0.01% 4527
2020
Q3
$58K Sell
23,614
-630
-3% -$1.55K ﹤0.01% 4308
2020
Q2
$86K Sell
24,244
-136,752
-85% -$485K ﹤0.01% 4198
2020
Q1
$377K Buy
160,996
+119,718
+290% +$280K ﹤0.01% 3638
2019
Q4
$91K Buy
41,278
+8,900
+27% +$19.6K ﹤0.01% 4141
2019
Q3
$59K Sell
32,378
-125,787
-80% -$229K ﹤0.01% 4108
2019
Q2
$229K Buy
158,165
+99,580
+170% +$144K ﹤0.01% 3821
2019
Q1
$115K Buy
58,585
+15,135
+35% +$29.7K ﹤0.01% 3996
2018
Q4
$57K Sell
43,450
-7,001
-14% -$9.18K ﹤0.01% 3960
2018
Q3
$124K Buy
50,451
+7,246
+17% +$17.8K ﹤0.01% 3909
2018
Q2
$145K Buy
43,205
+30,502
+240% +$102K ﹤0.01% 3952
2018
Q1
$54K Buy
+12,703
New +$54K ﹤0.01% 4079
2017
Q4
Sell
-13,931
Closed -$53K 4348
2017
Q3
$53K Sell
13,931
-12,725
-48% -$48.4K ﹤0.01% 4114
2017
Q2
$117K Buy
+26,656
New +$117K ﹤0.01% 4107
2015
Q4
Sell
-10,487
Closed -$36K 4652
2015
Q3
$36K Buy
+10,487
New +$36K ﹤0.01% 4391